CCL22 and breast neoplasm: CCL22 is highly expressed in a variety of malignant tumors including ovarian tumor, colorectal tumor, breast tumor, hepatocellular carcinoma and follicular lymphoma, and is related to poor prognosis29, 30, 31, 32, 33.